SCHEMBL30007941

SCHEMBL30007941

CC(C(=O)O)c1c(-c2ccc(F)cc2)[nH]c2c(F)cc(F)cc12

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APOL1 O14791 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28974875 1.00 APOL1 (0.49) APOL1
SCHEMBL30218288 0.90 APOL1 (0.45) APOL1
SCHEMBL30218358 0.88 APOL1 (0.40) APOL1
SCHEMBL31006363 0.85 APOL1 (0.36) APOL1
SCHEMBL22161369 0.84 APOL1 (0.48) APOL1
SCHEMBL22118318 0.84 APOL1 (0.48) APOL1
SCHEMBL30218333 0.84 APOL1 (0.50) APOL1
SCHEMBL30218341 0.84 APOL1 (0.49) APOL1
SCHEMBL28974842 0.82 APOL1 (0.48) APOL1
SCHEMBL22118432 0.80 APOL1 (0.62) APOL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115867532-A Inhibitors of APOL1 and uses thereof 弗特克斯药品有限公司 2023-03-28 CN disclosed
CN-115867543-A Solid forms of an APOL1 inhibitor and methods of use thereof 弗特克斯药品有限公司 2023-03-28 CN disclosed
CN-115209894-A Method for treating APOL-1 dependent focal segmental glomerulosclerosis 弗特克斯药品有限公司 2022-10-18 CN disclosed